Literature DB >> 23741429

Filling the gap 115 years after Ronald Ross: the distribution of the Anopheles coluzzii and Anopheles gambiae s.s from Freetown and Monrovia, West Africa.

Dziedzom K de Souza1, Benjamin G Koudou, Fatorma K Bolay, Daniel A Boakye, Moses J Bockarie.   

Abstract

It was in Freetown, Sierra Leone, that the malaria mosquito Anopheles coastalis, now known as Anopheles gambiae, was first discovered as the vector of malaria, in 1899. That discovery led to a pioneering vector research in Sierra Leone and neighbouring Liberia, where mosquito species were extensively characterized. Unfortunately, the decade long civil conflicts of the 1990s, in both countries, resulted in a stagnation of the once vibrant research on disease vectors. This paper attempts to fill in some of the gaps on what is now known of the distribution of the sibling species of the An. gambiae complex, and especially the An. coluzzii and An. gambiae s.s, formerly known as the An. gambiae molecular M and S forms respectively, in the cities of Freetown and Monrovia.

Entities:  

Mesh:

Year:  2013        PMID: 23741429      PMCID: PMC3669227          DOI: 10.1371/journal.pone.0064939

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Anopheles gambiae (formally known An. coastalis) was first incriminated as a vector of malaria by Sir Ronald Ross in Freetown, Sierra Leone in 1899 [1]. Mosquitoes belonging to the Anopheles gambiae complex are the major vectors of malaria in West Africa. As such studying their distribution, ecology and population structure is essential for effective malaria control programs. In the majority of West African countries, various studies on these important vectors have been undertaken in details. However, there is a gap in knowledge of these vectors in post conflict countries such as Sierra Leone and Liberia where ecological studies could not be undertaken in the 1990s and early 2000s because of the civil war that engulfed both countries for more than a decade. Prior to the civil unrest in these countries, the mosquito species and their distribution were largely documented. Sierra Leone primarily served as the centre of malaria vector research and control, being the place where human malarial parasites were first observed in wild-caught An. gambiae and An. funestus, in 1899 [1]. By the 1950s extensive studies on human biting mosquitoes in both Sierra Leone [1] and Liberia [2]–[5] had been undertaken. However, these studies were focussed on the morphological identification of these important vectors. By the 1980s the study of An. gambiae vectors of malaria in West Africa had evolved from morphometric to cytotaxonomic studies [6], [7]. The development of the PCR in 1990 [8] led to a further evolution in the identification of the sibling species of the An. gambiae complex [9], the M and S molecular forms of the An. gambiae s.s. [10] and knockdown resistance markers to insecticides [11], [12] using molecular methods. Following molecular and bionomical evidence, the An. gambiae molecular M form has subsequently been renamed An. coluzzii, whiles the An. gambiae molecular S form retained the name An. gambiae s.s [13]. These studies have been undertaken and enhanced malaria control activities in most countries in West Africa. Unfortunately, the civil conflict in Liberia (1989–1996, 1999–2003) and Sierra Leone (1991–2002) stagnated the once vibrant malaria vector research activities in the cities of Monrovia and Freetown. To date, no molecular identification of members of the An. gambiae complex had been undertaken/published in Sierra Leone, and in Liberia only one study [14] has described the distribution of the M and S forms of the An. gambiae s.s and their kdr frequencies in the Bomi County. In this short communication, we report the distribution of the An. coluzzii and the An. gambiae s.s., in Freetown and Monrovia the capital cities of Sierra Leone and Liberia respectively.

Methods

Study Sites

In Sierra Leone, samples were collected in November-December 2009, from 89 households in 5 communities around Freetown. In Liberia, samples were collected in July 2011, from 100 households in 4 communities in Monrovia (See Figures 1 and 2 below). Samples were collected using the pyrethrum spray method. In each community, samples were collected early in the morning between 5 and 9 am, in different households, over a 3 days period.
Figure 1

Distribution of the mosquito species, the An. coluzzii and the An. gambiae s.s from the sample communities in Freetown, Sierra Leone.

Figure 2

Distribution of the mosquito species, the An. coluzzii and the An. gambiae s.s from the sample communities in Monrovia, Liberia.

The collected samples were identified morphologically and the Anopheles species were stored individually on silica gel, while the Culex spp. specimens were put together in pools of 20. Other mosquito species were also stored separately. The collected samples were brought to the Noguchi Memorial Institute for Medical Research, Ghana, for molecular identification.

Molecular Studies

Genomic DNA was extracted from 2–3 legs from each mosquito, using the boil preparation method. Briefly, the legs were crushed in 100 µl of distilled water and boiled at 95°C for 10 minutes. The supernatant was used as template for the PCR. The extracted DNA was used for species identification using Polymerase Chain Reaction, Restriction Fragment Length Polymorphism (PCR-RFLP) [10]. The determination of the knockdown mutation conferring resistance to pyrethroids was undertaken using the method of Martinez-Torres et al [11].

Ethics Statement

Approval for this study was obtained from the IRB of the Liverpool School of Tropical Medicine and the Ethics and Scientific Review Committees of the Ministries of Health in Sierra Leone and Liberia. The communities, where sampling was done, were informed on the project and consent sought from the local authorities within each community. Consent was also sought from the households where mosquito sampling was carried out.

Results and Discussion

Specimen Collection and Morphological Identification

The number of collections from each community in Freetown is shown in Table 1. Overall, 206 An. gambiae and 749 Culex species were collected. In Monrovia, 161 and 381 An. gambiae and Culex species were collected respectively. Culex was the most common mosquito species collected, due to the polluted breeding waters found in the areas where the collections were made. An. funestus and Aedes spp. were also collected, but in very low numbers. The distribution of the mosquito species collected in Freetown and Monrovia is shown in Figure 1A and 2A respectively.
Table 1

Number of mosquito collections from each community in Freetown, Sierra Leone.

CountryCommunity An. gambiae Culex sp. Aedes sp. An. funestus
Sierra Leone Kissy 11622
George Brook 20170
Aberdeen 33465
Gbedembu 137493
York 53
Total 206 749 2 3
Liberia Clara Town 25703
New Kru Town 4372
King Gray 6189
Togba Camp 32871
Total 161 318 3 1

Molecular Identification and Distribution of the An. coluzzii and An. gambiae s.s

194 samples were analyzed for the molecular identification of the members of the An. gambiae complex in Freetown. 182 (93.8%) were successfully identified as either An. coluzzii or An. gambiae s.s. The remaining 12 samples failed to amplify. Further differentiation revealed 63.2% of the samples analyzed to be An. gambiae s.s., while the remaining 36.8% were An. coluzzii. The distribution of An. gambiae s.s. and An. coluzzii is shown in Figure 1B below. This study is the first to analyze the distribution of the An. gambiae s.s. and An. coluzzii in Freetown, Sierra Leone. Sierra Leone is a mountainous, forested region and this may explain the high proportion of An. gambiae s.s. compared to An. coluzzii, and is in accordance with a study [15] that showed that the An. gambiae molecular S form was dominant in mountainous, forested areas. In Monrovia, 105 mosquitoes morphologically identified as An. gambiae were analyzed. Out of these, 90.5% were identified as An. coluzzii, and the remaining 9.5% as An. gambiae s.s. These results are consistent with the results of Temu and colleagues [14] which showed 98% of samples identified to be the An. gambiae molecular M form in the Bomi County. Figure 2B shows the distribution of An. gambiae s.s. and An. coluzzii in the collection sites in Monrovia.

Distribution of Knockdown Resistance Mutations

Very high proportions of kdr mutations (96.2%) were detected in the An. gambiae populations (Table 2). The mutation was present both in An. gambiae s.s. and An. coluzzii, but was more common in the An. gambiae s.s. Few hybrids were also detected. The presence of the kdr mutation was initially thought to be only present in the An. gambiae molecular S form. However, studies have shown its occurrence in the An. gambiae molecular M form [16]–[20]. This study showed the mutation in 91% of the An. coluzzii identified, similar to values recently reported in the An. gambiae molecular M form in Cote d’Ivoire [20]. It is suggested that the presence of the mutation in the M form may be a result of introgression from the S form [17]. However, observations from the Island of Bioko-Equatorial Guinea, where the mutation was only observed in the M form [19], suggested that the mutation in the M form may have arisen independently due to intensive insecticide application.
Table 2

The distribution of the kdr allele in the An. coluzzii and the An. gambiae s.s in Freetown.

kdr Allele
Communities An. spp RRSSRS
Aberdeen An. coluzzii 85.7% (12)14.3% (2)
An. gambiae s.s100% (12)
Gbedembu An. coluzzii 93.2% (41)6.8% (3)
An. gambiae s.s97.4% (74)2.6% (2)
George Brook An. coluzzii 66.7% (2)33.3% (1)
An. gambiae s.s88.2% (15)5.9% (1)5.9% (1)
Kissi An. coluzzii 100% (4)
An. gambiae s.s100% (7)
York An. coluzzii 100% (2)
An. gambiae s.s100% (3)
Total An. coluzzii 91.1% (61) 8.9% (6)
An. gambiae s.s 96.5% (111) 0.9% (1) 2.6% (3)
The very high levels of kdr resistance to pyrethroids might be due to the high usage of insecticides (e.g. BHC and DDT) for malaria control activities in Sierra Leone, with possible cross resistance to pyrethroids. Studies conducted in the late 1950’s, on the development of insecticide resistance in the An. gambiae in Freetown, showed the factor conferring resistance to BHC in 66% of the population [21]. Dieldrin resistance was observed in 91–100% of An. gambiae populations in neighboring Liberia in 1957 [22] and was reported in Freetown in 1966 [23]. HCH and DDT were widely used for house spraying and larviciding in Freetown after the World War II [1]. Temephos and malathion were also used for larviciding until it was realized that control activities were unsuccessful, with a possible resistance to malathion [1]. Despite these reports we cannot conclusively assign the observed high levels of kdr only to insecticide use in the 1950’s and further studies will be required to assess this. While the frequencies of kdr mutations were not determined for the Monrovia samples, it is believed that the situation may not be much different from Freetown, considering the mosquito control activities that were in place in the 1950s [1], [24]. Also, recent studies in the Bomi County revealed kdr frequencies of over 90% [14]. Although these results may represent initial information, it was recently demonstrated that there is no significant association between the presence of the 1014F kdr allele and ability to survive exposure to pyrethroid [20]. Thus insecticide susceptibility testing and bio-assay data are necessary to validate our findings.

Conclusions

The distribution of the An. coluzzii and An. gambiae s.s and prevalence of the kdr gene are described here for the first time in Sierra Leone, nearly 115 years after the incrimination of the Anopheles mosquito as the vector of malaria. This study showed that the An. gambiae s.s is the most dominant sibling species of An. gambiae complex in Freetown, while the An. coluzzii is the dominant species in Monrovia. A high prevalence of kdr mutation has been observed in both An. coluzzii and An. gambiae s.s in Freetown. There is however a limitation to these results, in that the determination of the kdr frequencies was not undertaken on surviving or dead mosquitoes exposed to pyrethroids through insecticide susceptibility testing. However, due to the high levels of kdr mutation in the An. coluzzii and An. gambiae s.s populations, it is recommended that insecticide susceptibility testing be done on non-pyrethroids insecticides (organophosphates and carbamates) in order to determine the insecticide of choice for future vector control activities.
  19 in total

1.  The kdr mutation occurs in the Mopti form of Anopheles gambiae s.s. through introgression.

Authors:  M Weill; F Chandre; C Brengues; S Manguin; M Akogbeto; N Pasteur; P Guillet; M Raymond
Journal:  Insect Mol Biol       Date:  2000-10       Impact factor: 3.585

2.  Variation in an intron sequence of the voltage-gated sodium channel gene correlates with genetic differentiation between Anopheles gambiae s.s. molecular forms.

Authors:  G Gentile; F Santolamazza; C Fanello; V Petrarca; A Caccone; A della Torre
Journal:  Insect Mol Biol       Date:  2004-08       Impact factor: 3.585

3.  Anopheles coluzzii and Anopheles amharicus, new members of the Anopheles gambiae complex.

Authors:  Maureen Coetzee; Richard H Hunt; Richard Wilkerson; Alessandra Della Torre; Mamadou B Coulibaly; Nora J Besansky
Journal:  Zootaxa       Date:  2013       Impact factor: 1.091

4.  It all began with Ronald Ross: 100 years of malaria research and control in Sierra Leone (1899-1999).

Authors:  M J Bockarie; A A Gbakima; G Barnish
Journal:  Ann Trop Med Parasitol       Date:  1999-04

5.  An unusual distribution of the kdr gene among populations of Anopheles gambiae on the island of Bioko, Equatorial Guinea.

Authors:  L J Reimer; F Tripet; M Slotman; A Spielman; E Fondjo; G C Lanzaro
Journal:  Insect Mol Biol       Date:  2005-12       Impact factor: 3.585

6.  Species abundance and insecticide resistance of Anopheles gambiae in selected areas of Ghana and Burkina Faso.

Authors:  A E Yawson; P J McCall; M D Wilson; M J Donnelly
Journal:  Med Vet Entomol       Date:  2004-12       Impact factor: 2.739

7.  Environmental factors associated with the distribution of Anopheles gambiae s.s in Ghana; an important vector of lymphatic filariasis and malaria.

Authors:  Dziedzom de Souza; Louise Kelly-Hope; Bernard Lawson; Michael Wilson; Daniel Boakye
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

8.  Identification of single specimens of the Anopheles gambiae complex by the polymerase chain reaction.

Authors:  J A Scott; W G Brogdon; F H Collins
Journal:  Am J Trop Med Hyg       Date:  1993-10       Impact factor: 2.345

Review 9.  Chromosomal differentiation and adaptation to human environments in the Anopheles gambiae complex.

Authors:  M Coluzzi; A Sabatini; V Petrarca; M A Di Deco
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

10.  Pyrethroid resistance in Anopheles gambiae, in Bomi County, Liberia, compromises malaria vector control.

Authors:  Emmanuel A Temu; Caroline Maxwell; Godwil Munyekenye; Annabel F V Howard; Stephen Munga; Silas W Avicor; Rodolphe Poupardin; Joel J Jones; Richard Allan; Immo Kleinschmidt; Hilary Ranson
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

View more
  8 in total

1.  Low prevalence of Plasmodium and absence of malaria transmission in Conakry, Guinea: prospects for elimination.

Authors:  Bernard L Kouassi; Dziedzom K de Souza; Andre Goepogui; Siradiou M Balde; Lamia Diakité; Arsène Sagno; Georgina I Djameh; Frédérique Chammartin; Penelope Vounatsou; Moses J Bockarie; Jürg Utzinger; Benjamin G Koudou
Journal:  Malar J       Date:  2016-03-18       Impact factor: 2.979

2.  Diversity in breeding sites and distribution of Anopheles mosquitoes in selected urban areas of southern Ghana.

Authors:  Precious A Dzorgbe Mattah; Godfred Futagbi; Leonard K Amekudzi; Memuna M Mattah; Dziedzorm K de Souza; Worlasi D Kartey-Attipoe; Langbong Bimi; Michael D Wilson
Journal:  Parasit Vectors       Date:  2017-01-13       Impact factor: 3.876

3.  Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.

Authors:  Yakuba M Bah; Jusufu Paye; Mohamed S Bah; Abdulai Conteh; Victoria Redwood-Sawyerr; Mustapha Sonnie; Amy Veinoglou; Joseph B Koroma; Mary H Hodges; Yaobi Zhang
Journal:  PLoS Negl Trop Dis       Date:  2020-12-28

4.  Assessing Anopheles vector species diversity and transmission of malaria in four health districts along the borders of Côte d'Ivoire.

Authors:  Firmain N Yokoly; Julien B Z Zahouli; Graham Small; Allassane F Ouattara; Millicent Opoku; Dziedzom K de Souza; Benjamin G Koudou
Journal:  Malar J       Date:  2021-10-18       Impact factor: 2.979

5.  Entomological and Molecular Surveillance of Anopheles Mosquitoes in Freetown, Sierra Leone, 2019.

Authors:  Ning Zhao; Ishaq Sesay; Hong Tu; Frederick Yamba; Liang Lu; Yuhong Guo; Xiuping Song; Jun Wang; Xiaobo Liu; Yujuan Yue; Haixia Wu; Qiyong Liu
Journal:  Front Public Health       Date:  2021-06-17

6.  Assessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea.

Authors:  Bernard L Kouassi; Dziedzom K de Souza; Andre Goepogui; Charles A Narh; Sandra A King; Baldé S Mamadou; Lamia Diakité; Samuel K Dadzie; Daniel A Boakye; Jürg Utzinger; Moses J Bockarie; Benjamin G Koudou
Journal:  Parasit Vectors       Date:  2015-09-26       Impact factor: 3.876

7.  A geostatistical analysis of the association between armed conflicts and Plasmodium falciparum malaria in Africa, 1997-2010.

Authors:  Luigi Sedda; Qiuyin Qi; Andrew J Tatem
Journal:  Malar J       Date:  2015-12-16       Impact factor: 2.979

8.  Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.

Authors:  Dung D Pam; Dziedzom K de Souza; Susan D'Souza; Millicent Opoku; Safiya Sanda; Ibrahim Nazaradden; Ifeoma N Anagbogu; Chukwu Okoronkwo; Emmanuel Davies; Elisabeth Elhassan; David H Molyneux; Moses J Bockarie; Benjamin G Koudou
Journal:  PLoS Negl Trop Dis       Date:  2017-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.